Related Experiment Video
Updated: Feb 14, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
NOD2-RIP2 contributes to the inflammatory responses of mice in vivo to Streptococcus pneumoniae
Yuan Zheng1, Feng Shang2, Li An1
1Department of Pediatrics, Jinan Central Hospital Affiliated with Shandong University, Jinan, Shandong, China.
Abstract:
The objectives of this study were to investigate the role of the NOD2-RIP2 pathway in host responses to the gram-positive bacteria Streptococcus pneumoniae and to evaluate the effect of the RIP2 inhibitor gefitinib in a mouse model of S. pneumoniae meningitis. Mice were randomly divided into a normal saline control group (NS group), an S. pneumoniae meningitis group (SP group), a gefitinib group and a vehicle group. Animals in the NS group were sham-infected with sterile saline. Mice in the other three groups were inoculated with S. pneumoniae and left untreated, treated with gefitinib, or treated with vehicle. The results revealed upregulation of the mRNA and protein levels of NOD2, RIP2, NF-κB, TNF-α and IL-6 within the CNS of mice with S. pneumoniae meningitis. Moreover, mice in the meningitis group were severely ill and demonstrated a significant loss of neurons. Treatment with the RIP2 inhibitor gefitinib showed less intense activation of NF-kB, decreased TNF-α and IL-6, attenuated neuronal injury and improved illness. These results suggest that NOD2-RIP2 is involved in the host response to the gram-positive bacteria S. pneumoniae in the CNS and that the RIP2 inhibitor gefitinib protects the brain from damage caused by S. pneumoniae.
Insights
The NOD2-RIP2 pathway is involved in Streptococcus pneumoniae meningitis. The RIP2 inhibitor gefitinib reduces inflammation and protects neurons in a mouse model, offering a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Immunology
- Microbiology
Background:
- Streptococcus pneumoniae is a common cause of bacterial meningitis.
- The NOD2-RIP2 pathway plays a role in innate immunity and inflammation.
- Understanding host responses is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of the NOD2-RIP2 pathway in S. pneumoniae meningitis.
- To evaluate the therapeutic potential of the RIP2 inhibitor gefitinib.
Main Methods:
- A mouse model of S. pneumoniae meningitis was established.
- Mice were treated with gefitinib or vehicle.
- NOD2-RIP2 pathway activation, inflammatory markers, and neuronal injury were assessed.
Main Results:
- S. pneumoniae meningitis upregulated NOD2, RIP2, NF-κB, TNF-α, and IL-6 in the CNS.
- Meningitis led to severe illness and significant neuronal loss.
- Gefitinib treatment reduced NF-κB activation, inflammatory cytokine levels, and neuronal damage.
Conclusions:
- The NOD2-RIP2 pathway is implicated in the host response to S. pneumoniae in the central nervous system.
- Gefitinib demonstrates neuroprotective effects against S. pneumoniae-induced brain damage.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Binet's Contribution to Measures of Intelligence

